Claret Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-25,181
Closed -$180K 346
2024
Q2
$180K Buy
25,181
+14,233
+130% +$102K 0.03% 244
2024
Q1
$95K Sell
10,948
-862
-7% -$7.48K 0.02% 207
2023
Q4
$77K Buy
11,810
+132
+1% +$861 0.01% 189
2023
Q3
$117K Hold
11,678
0.02% 149
2023
Q2
$145K Buy
+11,678
New +$145K 0.03% 149